Previous symbols: TCF14, MODY, MODY1. Aliases: NR2A1, HNF4.
HNF4A (hepatocyte nuclear factor 4 alpha) is named by 5 disorder entries.
Three entries type HNF4A as causative, Congenital Isolated Hyperinsulinism; Diabetes mellitus; and Hyperinsulinemic Hypoglycemia, all with germline variants (Congenital Isolated Hyperinsulinism; Diabetes mellitus; and Hyperinsulinemic Hypoglycemia). The gene sits on HNF4A-Dependent Fetal and Neonatal Beta-Cell Dysregulation in Congenital Isolated Hyperinsulinism and on Transcription Factor Dysregulation of the Beta-Cell Secretory Program in Hyperinsulinemic Hypoglycemia, where it shares the node with HNF1A. In Diabetes mellitus the record is scoped to the monogenic diabetes subtype, for which ClinGen rates the gene definitive; ClinGen classifies HNF4A for 1 disease.
Two entries carry HNF4A with no relationship type: Fanconi Renotubular Syndrome; and Ulcerative Colitis. Fanconi Renotubular Syndrome places HNF4A on Proximal tubular transport and energy-metabolism defect.
The KB annotates HNF4A nodes with establishment of endothelial intestinal barrier; insulin secretion; oxidative phosphorylation; regulation of insulin secretion; and renal absorption, all downstream physiological processes. HNF4A is a nuclear-receptor transcription factor; both hyperinsulinism nodes bind DNA-binding transcription activator activity as decreased. The ai-gene-review layer pinned in the ingest lists 0 core-function terms for HNF4A, so the layers share 0 GO terms. An upstream review centred on nuclear receptor (DNA-binding transcription factor) activity is being completed.
Underlined values are claims re-computed from the knowledge base each time this page is built. The tables below are the source of truth.
Relationship is the entry's genetic[].relationship_type. untyped means the entry has a genetic record for the gene but does not type it; its free-text association is shown instead.
| Disorder | Relationship | Where the gene appears |
|---|---|---|
| Congenital Isolated Hyperinsulinism | causative germline |
mechanism: HNF4A-Dependent Fetal and Neonatal Beta-Cell Dysregulation
subtype: HNF4A/HNF1A-HI
scoped to subtype: HNF4A/HNF1A-HI
|
| Diabetes mellitus |
causative
germline
CLINGEN: definitive (monogenic diabetes)
|
mechanism: Monogenic Beta-Cell Dysfunction
subtype: maturity-onset diabetes of the young type 1
scoped to subtype: monogenic diabetes
|
| Hyperinsulinemic Hypoglycemia | causative germline |
mechanism: Transcription Factor Dysregulation of the Beta-Cell Secretory Program
|
| Fanconi Renotubular Syndrome |
untyped
Causative
|
mechanism: Proximal tubular transport and energy-metabolism defect
subtype: FRTS4
|
| Ulcerative Colitis |
untyped
Risk Factor
|
mechanism: Epithelial Barrier Dysfunction
|
An entry matches when ClinGen's MONDO disease is the entry's own disease term, a subtype term, or an exact-match mapping. An amber status marks an entry ClinGen supports the gene for (Definitive, Strong or Moderate) whose own record does not type it. A Limited, Disputed or Refuted tier on such an entry is not a gap.
| ClinGen disease | MOI | Classification | dismech entry |
|---|---|---|---|
| monogenic diabetes MONDO:0015967 | AD | Definitive 2019-02-27 |
Diabetes mellitus
causative
|
Identity from HGNC (snapshot 2026-10-01). Page layers are described in the gene pages documentation.